N/A
Completed N=300
Evaluation of Wound Infection Rates and Cosmetic Results of Different Suture Materials in Cesarean Skin Incision
Cesarean Section; Infection · Scar
Source: ClinicalTrials.gov NCT06119113 ↗
Enrolled (actual)
300
Serious AEs
0.0%
Results posted
Dec 2025
Primary outcomePrimary: Evaluation of the Difference Between the Groups in the Number of Patients With Wound Infection at the End of the 10th Postoperative Day — 80; 90; 93; 12 Participants
Summary
Our primary aim is to determine the most beneficial suture in order to reduce complications due to skin incision in common surgeries such as cesarean section, and our secondary aim is to evaluate the suture material used in terms of cosmetic results and participant preference.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Evaluation of the Difference Between the Groups in the Number of Patients With Wound Infection at the End of the 10th Postoperative Day |
80; 90; 93; 12; 5; 3 | — |
| PRIMARY Comparison of Incision Cosmetic Results Between Group 1 (Vicryl Suture™(Polyglactin 910)) and Group 2 (Prolene Suture™(Polypropylene)) at the End of the 2nd Postoperative Month and at the End of the 6th Postoperative Month by POSAS |
26.9; 20.5; 20.9; 16.5 | — |
| PRIMARY Comparison of Incision Cosmetic Results Between Group 1 (Vicryl Suture™(Polyglactin 910)) and Group 3 (Tekmon Suture™(Poliglekapron 25)) at the End of the 2nd Postoperative Month and at the End of the 6th Postoperative Month by POSAS |
26.9; 18.7; 20.9; 14.5 | — |
| PRIMARY Comparison of Incision Cosmetic Results Between Group 2 (Prolene Suture™(Polypropylene)) and Group 3 (Tekmon Suture™(Poliglekapron 25)) at the End of the 2nd Postoperative Month and at the End of the 6th Postoperative Month by POSAS |
20.5; 18.7; 16.5; 14.5 | — |
| PRIMARY Comparison of Incision Cosmetic Results Between Group 1(Vicryl Suture™(Polyglactin 910)) and Group 2(Prolene Suture™(Polypropylene)) at the End of the 2nd Postoperative Month and at the End of the 6th Postoperative Month by The Vancouver Scar Scale (VSS) |
4; 3; 3; 3 | — |
| PRIMARY Comparison of Incision Cosmetic Results Between Group 1(Vicryl Suture™(Polyglactin 910)) and Group 3(Tekmon Suture™(Poliglekapron 25)) at the End of the 2nd Postoperative Month and at the End of the 6th Postoperative Month by The Vancouver Scar Scale(VSS) |
4; 3; 3; 2 | — |
| PRIMARY Comparison of Incision Cosmetic Results Between Group 2(Prolene Suture™(Polypropylene)) and Group 3(Tekmon Suture™(Poliglekapron 25)) at the End of the 2nd Postoperative Month and at the End of the 6th Postoperative Month by The Vancouver Scar Scale(VSS) |
3; 3; 3; 2 | — |
Eligibility Criteria
Inclusion Criteria
- 18-45 years old
- Patients who had a primary cesarean section at our >37w hospital
- Patients with a Pfannenstiel incision closed subcutaneously
Exclusion Criteria
- Women <18 years and >45 years old
- Those with a history of keloid
- Suprapubic incision due to previous surgery
- Signs of infection at or near the incision during cesarean section
- Known hypersensitivity to any of the suture materials used
- Having a medical condition that causes immunosuppression, such as DM, chronic corticosteroid use
- Failure to obtain informed consent from the patient
Data sourced from ClinicalTrials.gov (NCT06119113). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.